Skip to main content
. 2022 Jun 29;20(8):1479–1497. doi: 10.2174/1570159X19666210915122820

Fig. (9).

Fig. (9)

The low bioavailability of 7,8-DHF could be overcome by modifying the structure of 7,8-DHF through prodrug strategy, glycation, derivative compounds, and molecular docking methods and preparing 7,8-DHF nano-preparations. (DHF-Z-S: 7,8-DHF loaded zein-sophorolipid nanoparticles, zein/LF-DHF: 7,8-DHF loaded zein/lactoferrin composite nanoparticles).